Publications
Recent advances using genetic therapies against infectious diseases and for vaccination Vrije Universiteit Brussel
The development of prophylatic or therapeutic medicines for infectious diseases is one of the priorities for health organizations worldwide. Innovative solutions are required to achieve effective, safe, and accessible treatments for most if not all infectious diseases, particularly those that are chronic in nature or that emerge unexpectedly over time. Genetic technologies offer versatile possibilities to design therapies against pathogens. ...
Effectiveness of educational outreach in infectious diseases management University of Antwerp
Animal ownership and touching enrich the context of social contacts relevant to the spread of human infectious diseases University of Antwerp
European society for paediatric infectious diseases consensus recommendations for rotavirus vaccination in Europe update 2014 University of Antwerp
The French Connection: The First Large Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases Hasselt University
Do we over- or underestimate the overall cost burden of infectious diseases in ageing adults? University of Antwerp
On a model for the cross protection Of two infectious diseases University of Antwerp
Overcoming publication and dissemination bias in infectious diseases clinical trials Institute of Tropical Medicine
Non-timely reporting, selective reporting, or non-reporting of clinical trial results are prevalent and serious issues. WHO mandates that summary results be available in registries within 12 months of study completion and published in full text within 24 months. However, only a limited number of clinical trials in infectious diseases, including those done during the COVID-19 pandemic, have their results posted on ClinicalTrials.gov. An ...